查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1971506

性傳染病自我檢測市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、區域和競爭格局分類，2021-2031年

STD Self-Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球性行為感染(STI) 自檢市場預計將從 2025 年的 12.9 億美元成長到 2031 年的 20.2 億美元，複合年成長率達到 7.76%。

該市場涵蓋允許個人私密採集生物檢體並即時獲得結果或進行後續檢查室分析的診斷產品。推動該市場發展的主要因素是性行為感染傳染病的蔓延，這使得人們對便捷、易用的篩檢方法產生了迫切需求。此外，消費者對隱私日益成長的需求，以及遠端醫療服務的無縫整合，也促進了這些便捷檢測方案的廣泛接受和應用。

市場概覽
預測期 2027-2031
市場規模：2025年 12.9億美元
市場規模：2031年 20.2億美元
複合年成長率：2026-2031年 7.76%
成長最快的細分市場 愛滋病毒檢測
最大的市場 北美洲

根據美國性健康協會發布的2025年報告，上年度美國報告的性行為感染感染病例約有220萬例。儘管市場需求強勁，但家用診斷試劑盒嚴格的監管環境嚴重阻礙了市場成長。衛生部門始終將確保未經訓練的使用者所採集的檢體的準確性放在首位，而這項擔憂也限制了消費性新核准速度。

市場促進因素

性行為感染感染（STI）在全球範圍內的日益蔓延是推動性傳染病自檢市場發展的主要因素，也使得便利的篩檢工具成為一項重要的公共衛生需求。隨著不同人群感染率的上升，傳統的診所檢測機構不堪重負，促使人們轉向私人的、用戶主導的診斷​​方式。這種趨勢在弱勢群體中尤其明顯，因為諸如社會歧視和預約限制等障礙阻礙了他們及時獲得診斷。例如，歐洲疾病預防控制中心（ECDC）在2025年12月報告稱，2021年至2023年間，20至24歲女性淋病報告率成長了約200%，這凸顯了在臨床環境之外增加檢測能力的必要性。

同時，越來越多的家用診斷設備獲得監管機構核准，解決了人們對檢測可靠性和檢體準確性的傳統擔憂，從而推動了市場發展。監管機構正在擴大對無需處方箋即可提供檢查室層級檢測結果的市售分子檢測的批准範圍，從而證實了自我檢測的臨床價值。例如，2025年3月，美國FDA批准了Visby Medical的女性健康檢測，該檢測在臨床試驗中檢出率高達97.2%的披衣菌感染衣原體陽性檢體。法規環境的這種變化緩解了人們對安全性的擔憂，並促進了其更廣泛的應用。此外，美國疾病管制與預防中心（CDC）2025年的數據顯示，約有4000例先天性梅毒病例，凸顯了早期發現對於避免嚴重健康損害的關鍵作用。

市場挑戰

嚴格的居家檢測法規結構對全球性行為感染）自檢市場的擴張構成重大障礙。衛生部門制定了嚴格的標準，以確保使用者自行採集的檢體檢測結果與專業醫護人員採集的樣本具有相同的臨床可靠性。這項要求迫使製造商在非受控環境下進行全面且高成本的可用性研究，以檢驗檢體靈敏度和檢體完整性，從而顯著延長核准流程並增加市場准入所需的資本投入。

法規核准的延誤直接阻礙了市場成長，限制了已通過核准產品的供應，而隨著全球感染疾病負擔的持續加重，這無疑是一個嚴峻的問題。緩慢的核准流程限制了業界滿足公眾對便利篩檢方法的迫切需求的能力。根據世界衛生組織（世衛組織）2024年的數據，四種可治療的性行為感染感染每天在全球造成超過一百萬例新增感染。感染率的激增與符合監管規定的自檢解決方案部署的延誤之間的差距，造成了供需缺口，限制了收入潛力，並減緩了這些技術的普及應用。

市場趨勢

遠端醫療和數位健康平台的融合正在重塑市場，建構一個超越單純診斷的綜合醫療生態系統。越來越多的自測產品包含虛擬諮詢和電子處方箋服務，確保檢測結果呈陽性者能及時獲得醫療救治。這種方式不僅能減輕患者的焦慮，還能透過遠距管理無症狀感染者來緩解實體醫療系統的負擔。這項轉變凸顯了人們對數位化性健康服務日益成長的需求，愛爾蘭衛生署的數據也印證了這一點：2024年，該機構共出貨126,090套家用性性行為感染檢測套組。

同時，醫生主導的直接面對消費者（CDM）銷售模式的興起，繞過了傳統的檢查室流程，使更多人能夠獲得臨床級別的診斷。製造商正大力投資擴大生產規模並建立直銷管道，使消費者無需事先進行面對面諮詢即可購買高精度分子檢測。這一趨勢促使企業對診斷設備的商業化策略進行大規模投資，將其作為消費健康產品進行銷售。例如，根據 MobiHealthNews 2025 年 6 月報道，Visby Medical 已籌集約 5,500 萬美元，用於加速其無需設備的 PCR 檢測平台的直接向消費者銷售。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球性傳染病自檢市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依申請項目（CT/NG掃描、梅毒檢測、HIV檢測等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美性傳染病自我檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲性傳染病自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區性傳染病自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲性傳染病自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美性傳染病自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球性傳染病自我檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories Inc.
  • autotest VIH Inc.
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics
  • NOWDiagnostics Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27723

The Global STD Self-Testing Market is projected to expand from USD 1.29 Billion in 2025 to USD 2.02 Billion by 2031, achieving a CAGR of 7.76%. This market encompasses diagnostic products designed to enable individuals to collect biological samples privately, either for immediate interpretation or subsequent laboratory analysis. The primary force driving this market is the increasing prevalence of sexually transmitted infections, which has generated an urgent demand for discreet and accessible screening options. Additionally, the growing consumer desire for privacy, coupled with the seamless integration of telehealth services, is bolstering the widespread acceptance and adoption of these convenient testing solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.29 Billion
Market Size 2031USD 2.02 Billion
CAGR 2026-20317.76%
Fastest Growing SegmentHIV Testing
Largest MarketNorth America

According to the American Sexual Health Association in 2025, approximately 2.2 million sexually transmitted infection cases were reported in the United States during the preceding year. Despite this robust demand, market growth encounters significant obstacles due to the strict regulatory environment governing home diagnostics. Health authorities continue to prioritize ensuring the accuracy of samples collected by untrained users, a concern that restricts the pace at which new products obtain approval for general consumer usage.

Market Driver

The increasing global prevalence of sexually transmitted infections acts as the main catalyst for the STD self-testing market, creating a critical public health requirement for accessible screening tools. As infection rates rise across various demographic groups, conventional clinic-based testing facilities struggle to handle the volume, prompting a shift toward private, user-led diagnostic options. This trend is especially noticeable among vulnerable populations where barriers such as stigma and scheduling conflicts hinder timely diagnosis. For instance, the European Centre for Disease Prevention and Control reported in December 2025 that gonorrhea notification rates among women aged 20 to 24 increased by nearly 200% between 2021 and 2023, highlighting the necessity for testing capabilities beyond clinical settings.

Concurrently, the market is being propelled by an increase in regulatory approvals for at-home diagnostic devices, which are addressing historical doubts concerning test reliability and sample accuracy. Regulators are increasingly authorizing over-the-counter molecular tests that provide lab-quality outcomes without a prescription, thus confirming the clinical value of self-testing. Notably, in March 2025, the U.S. FDA authorized the Visby Medical Women's Sexual Health Test, which identified 97.2% of positive Chlamydia trachomatis samples in clinical trials. This evolving regulatory environment mitigates safety concerns and promotes broader adoption, while 2025 data from the CDC showing nearly 4,000 cases of congenital syphilis further emphasizes the vital role of early detection in averting serious health consequences.

Market Challenge

Strict regulatory frameworks regarding home-based diagnostics present a substantial barrier to the expansion of the Global STD Self-Testing Market. Health authorities enforce rigorous standards to ensure that biological samples collected by lay users produce results that are clinically equivalent to those gathered by healthcare professionals. This requirement forces manufacturers to conduct comprehensive and expensive usability studies to verify test sensitivity and sample integrity in uncontrolled settings, significantly prolonging the approval process and raising the capital investment needed for market entry.

These regulatory delays directly hinder market growth by limiting the availability of approved products, even as the global burden of infections continues to rise. The slow pace of clearance restricts the industry's capacity to meet the urgent public health need for accessible screening methods. According to the World Health Organization in 2024, four curable sexually transmitted infections were responsible for over 1 million new infections every day globally. This disconnect between the surging infection rates and the delayed introduction of compliant self-testing solutions creates a gap between supply and demand that limits revenue potential and slows the widespread adoption of these technologies.

Market Trends

The convergence of telemedicine and digital health platforms is transforming the market by establishing a comprehensive care ecosystem that extends beyond simple diagnosis. Self-testing products are increasingly being packaged with virtual consultations and electronic prescription services, ensuring that individuals testing positive receive prompt medical attention. This approach not only reduces patient anxiety but also eases the burden on physical healthcare systems by managing asymptomatic cases remotely, a shift supported by data such as the Department of Health in Ireland reporting the dispatch of 126,090 home STI test kits in 2024, indicating growing demand for digitally managed sexual health services.

In parallel, the rise of physician-mediated direct-to-consumer models is democratizing access to clinical-grade diagnostics by bypassing traditional laboratory logistics. Manufacturers are securing significant investment to expand production and build direct retail channels, enabling consumers to purchase high-accuracy molecular tests without needing an initial in-person appointment. This trend involves substantial spending on commercialization strategies that market diagnostic devices as consumer health products; for example, in June 2025, MobiHealthNews reported that Visby Medical raised roughly $55 million to expedite the direct-to-consumer launch of its instrument-free PCR testing platform.

Key Market Players

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories Inc.
  • autotest VIH Inc.
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics
  • NOWDiagnostics Inc.

Report Scope

In this report, the Global STD Self-Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

STD Self-Testing Market, By Application

  • CT/NG Testing
  • Syphilis Testing
  • HIV Testing
  • Others

STD Self-Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global STD Self-Testing Market.

Available Customizations:

Global STD Self-Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global STD Self-Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2025)
  • 5.3. Market Map

6. North America STD Self-Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States STD Self-Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Canada STD Self-Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Mexico STD Self-Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe STD Self-Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany STD Self-Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. France STD Self-Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. United Kingdom STD Self-Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
    • 7.3.4. Italy STD Self-Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain STD Self-Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia Pacific STD Self-Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China STD Self-Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India STD Self-Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. Japan STD Self-Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. South Korea STD Self-Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia STD Self-Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. Middle East & Africa STD Self-Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia STD Self-Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. UAE STD Self-Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. South Africa STD Self-Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. South America STD Self-Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil STD Self-Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Colombia STD Self-Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. Argentina STD Self-Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global STD Self-Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. OraSure Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Selfdiagnostics Deutschland GmbH
  • 15.3. Wondfo BIOTECH CO., LTD.
  • 15.4. bioLytical Laboratories Inc.
  • 15.5. autotest VIH Inc.
  • 15.6. Abbott Laboratories
  • 15.7. Visby Medical Inc.
  • 15.8. PrivaPath Diagnostics
  • 15.9. NOWDiagnostics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer